<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font16">with </span>
   <span class="font15">for </span>
   <span class="font14">(). </span>
   <span class="font13">that </span>
   <span class="font13">patients </span>
   <span class="font13">&amp;amp; </span>
   <span class="font13">al.,Â </span>
   <span class="font12">virus </span>
   <span class="font12">â€". </span>
   <span class="font12">(), </span>
   <span class="font12">coronavirus </span>
   <span class="font12">has </span>
   <span class="font12">treatment </span>
   <span class="font12">â€¦ </span>
   <span class="font12">also </span>
   <span class="font12">antiviral </span>
   <span class="font12">used </span>
   <span class="font12">viral </span>
   <span class="font12">The </span>
   <span class="font12">are </span>
   <span class="font12">respiratory </span>
   <span class="font11">such </span>
   <span class="font11">{background </span>
   <span class="font11">SARSâ€�CoV </span>
   <span class="font11">J., </span>
   <span class="font11">against </span>
   <span class="font11">â€�nCoV </span>
   <span class="font11">COVIDâ€� </span>
   <span class="font11">effect </span>
   <span class="font11">was </span>
   <span class="font11">can </span>
   <span class="font11">ACE </span>
   <span class="font11">treat </span>
   <span class="font11">M., </span>
   <span class="font11">drug </span>
   <span class="font11">influenza </span>
   <span class="font11">margin </span>
   <span class="font11">use </span>
   <span class="font11">{border-style </span>
   <span class="font11">S., </span>
   <span class="font11">have </span>
   <span class="font11">infection </span>
   <span class="font11">A., </span>
   <span class="font11">inhibitor </span>
   <span class="font11">novel </span>
   <span class="font11">px;} </span>
   <span class="font11">remdesivir </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Journal </span>
   <span class="font11">Y., </span>
   <span class="font11">been </span>
   <span class="font11">effective </span>
   <span class="font11">R., </span>
   <span class="font11">W., </span>
   <span class="font11">Wang, </span>
   <span class="font11">but </span>
   <span class="font11">clinical </span>
   <span class="font11">severe </span>
   <span class="font11">L., </span>
   <span class="font11">corticosteroids </span>
   <span class="font11">this </span>
   <span class="font10">RNA </span>
   <span class="font10">its </span>
   <span class="font10">not </span>
   <span class="font10">which </span>
   <span class="font10">C., </span>
   <span class="font10">K., </span>
   <span class="font10">MERSâ€�CoV </span>
   <span class="font10">T., </span>
   <span class="font10">combination </span>
   <span class="font10">drugs </span>
   <span class="font10">from </span>
   <span class="font10">human </span>
   <span class="font10">protein </span>
   <span class="font10">showed </span>
   <span class="font10">than </span>
   <span class="font10">F., </span>
   <span class="font10">Zhang, </span>
   <span class="font10">early </span>
   <span class="font10">entry </span>
   <span class="font10">ribavirin </span>
   <span class="font10">therapeutic </span>
   <span class="font10">D., </span>
   <span class="font10">Liu, </span>
   <span class="font10">SARSâ€�CoVâ€� </span>
   <span class="font10">effects </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">replication </span>
   <span class="font10">treatments </span>
   <span class="font10">virus, </span>
   <span class="font10">viruses </span>
   <span class="font10">E., </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Li, </span>
   <span class="font10">activity </span>
   <span class="font10">acute </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">could </span>
   <span class="font10">favipiravir </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">inhibits </span>
   <span class="font10">into </span>
   <span class="font10">pneumonia </span>
   <span class="font10">reduces </span>
   <span class="font10">shown </span>
   <span class="font10">study </span>
   <span class="font10">were </span>
   <span class="font10">Medical </span>
   <span class="font10">SARSâ€�CoV, </span>
   <span class="font10">Virology, </span>
   <span class="font10">X., </span>
   <span class="font10">hepatitis </span>
   <span class="font10">potential </span>
   <span class="font10">receptor </span>
   <span class="font10">recommended </span>
   <span class="font10">spike </span>
   <span class="font10">H., </span>
   <span class="font10">Infectious </span>
   <span class="font10">LPV/r </span>
   <span class="font10">Medicine, </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">This </span>
   <span class="font10">University </span>
   <span class="font10">disease </span>
   <span class="font10">form </span>
   <span class="font10">host </span>
   <span class="font10">model </span>
   <span class="font10">px; </span>
   <span class="font10">results </span>
   <span class="font10">syndrome </span>
   <span class="font10">who </span>
   <span class="font10">{font-family </span>
   <span class="font10">ARDS </span>
   <span class="font10">COVIDâ€�, </span>
   <span class="font10">P., </span>
   <span class="font10">RBD </span>
   <span class="font10">active </span>
   <span class="font10">al. </span>
   <span class="font10">analog </span>
   <span class="font10">available </span>
   <span class="font10">cell </span>
   <span class="font10">chloroquine </span>
   <span class="font10">cytokine </span>
   <span class="font10">different </span>
   <span class="font10">font-size </span>
   <span class="font10">may </span>
   <span class="font10">mortality </span>
   <span class="font10">new </span>
   <span class="font10">nucleotide </span>
   <span class="font10">prevent </span>
   <span class="font10">specific </span>
   <span class="font10">studies </span>
   <span class="font10">their </span>
   <span class="font10">there </span>
   <span class="font10">â€‰mg </span>
   <span class="font10">.â€‰Î¼M </span>
   <span class="font10">Antiviral </span>
   <span class="font10">China, </span>
   <span class="font10">Department </span>
   <span class="font10">Diseases, </span>
   <span class="font10">Ebola </span>
   <span class="font10">Research, </span>
   <span class="font10">Used </span>
   <span class="font10">V., </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">cellular </span>
   <span class="font10">coronavirus. </span>
   <span class="font10">coronaviruses, </span>
   <span class="font10">damage </span>
   <span class="font10">days </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">high </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">immune </span>
   <span class="font10">including </span>
   <span class="font10">protease </span>
   <span class="font10">recovery </span>
   <span class="font10">response </span>
   <span class="font10">should </span>
   <span class="font10">spread </span>
   <span class="font10">target </span>
   <span class="font10">these </span>
   <span class="font10">twice </span>
   <span class="font10">virus. </span>
   <span class="font10">vitro </span>
   <span class="font10">well </span>
   <span class="font10">zanamivir </span>
   <span class="font10">Arbidol </span>
   <span class="font10">Chan, </span>
   <span class="font10">Cheng, </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">East </span>
   <span class="font10">G., </span>
   <span class="font10">MERSâ€�CoV, </span>
   <span class="font10">Middle </span>
   <span class="font10">SARS </span>
   <span class="font10">SARSâ€�CoV. </span>
   <span class="font10">Zhang </span>
   <span class="font10">acid </span>
   <span class="font10">acts </span>
   <span class="font10">any </span>
   <span class="font10">appropriate </span>
   <span class="font10">bat </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broadâ€�spectrum </span>
   <span class="font10">caused </span>
   <span class="font10">cells </span>
   <span class="font10">coronaviruses. </span>
   <span class="font10">daily </span>
   <span class="font10">enzyme </span>
   <span class="font10">genome </span>
   <span class="font10">guanosine </span>
   <span class="font10">had </span>
   <span class="font10">health </span>
   <span class="font10">infection. </span>
   <span class="font10">inflammatory </span>
   <span class="font10">known </span>
   <span class="font10">lopinavir </span>
   <span class="font10">lung </span>
   <span class="font10">more </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">other </span>
   <span class="font10">outbreak </span>
   <span class="font10">patient </span>
   <span class="font10">proliferation </span>
   <span class="font10">public </span>
   <span class="font10">receptor. </span>
   <span class="font10">recombinant </span>
   <span class="font10">reducing </span>
   <span class="font10">ribavirin, </span>
   <span class="font10">septic </span>
   <span class="font10">several </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">soluble </span>
   <span class="font10">some </span>
   <span class="font10">they </span>
   <span class="font10">through </span>
   <span class="font10">trial </span>
   <span class="font10">useful </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(GSâ€�) </span>
   <span class="font10">(LPV/r) </span>
   <span class="font10">(â€�nCoV). </span>
   <span class="font10">ARDS, </span>
   <span class="font10">Also, </span>
   <span class="font10">B., </span>
   <span class="font10">Baric, </span>
   <span class="font10">But </span>
   <span class="font10">COVIDâ€�. </span>
   <span class="font10">Cell </span>
   <span class="font10">Clinical </span>
   <span class="font10">Feldmann, </span>
   <span class="font10">GSâ€� </span>
   <span class="font10">Graham, </span>
   <span class="font10">HIV </span>
   <span class="font10">However, </span>
   <span class="font10">Hu, </span>
   <span class="font10">I., </span>
   <span class="font10">Lopinavir </span>
   <span class="font10">MPA </span>
   <span class="font10">Mycophenolic </span>
   <span class="font10">N., </span>
   <span class="font10">New </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Sciences, </span>
   <span class="font10">Semnan </span>
   <span class="font10">Sheahan </span>
   <span class="font10">Sun, </span>
   <span class="font10">Tan, </span>
   <span class="font10">Teicoplanin </span>
   <span class="font10">Wang </span>
   <span class="font10">Wu, </span>
   <span class="font10">Xu, </span>
   <span class="font10">addition </span>
   <span class="font10">alone </span>
   <span class="font10">analysis </span>
   <span class="font10">antibodies </span>
   <span class="font10">based </span>
   <span class="font10">because </span>
   <span class="font10">between </span>
   <span class="font10">binding </span>
   <span class="font10">blocks </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">care </span>
   <span class="font10">combined </span>
   <span class="font10">compound </span>
   <span class="font10">concentrations </span>
   <span class="font10">courier; </span>
   <span class="font10">decrease </span>
   <span class="font10">development </span>
   <span class="font10">direct </span>
   <span class="font10">doses </span>
   <span class="font10">duration </span>
   <span class="font10">each </span>
   <span class="font10">em; </span>
   <span class="font10">especially </span>
   <span class="font10">experience </span>
   <span class="font10">experimental </span>
   <span class="font10">first </span>
   <span class="font10">found </span>
   <span class="font10">global </span>
   <span class="font10">guidelines </span>
   <span class="font10">increase </span>
   <span class="font10">infected </span>
   <span class="font10">inhibitory </span>
   <span class="font10">invalid </span>
   <span class="font10">late </span>
   <span class="font10">low </span>
   <span class="font10">lungs </span>
   <span class="font10">mice </span>
   <span class="font10">mortality. </span>
   <span class="font10">neuraminidase </span>
   <span class="font10">nucleoside </span>
   <span class="font10">oral </span>
   <span class="font10">oxygen </span>
   <span class="font10">patients. </span>
   <span class="font10">polymerase </span>
   <span class="font10">prevents </span>
   <span class="font10">production </span>
   <span class="font10">progression </span>
   <span class="font10">protein, </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently </span>
   <span class="font10">reduced </span>
   <span class="font10">release </span>
   <span class="font10">research </span>
   <span class="font10">resistance </span>
   <span class="font10">rhesus </span>
   <span class="font10">significant </span>
   <span class="font10">stages </span>
   <span class="font10">stronger </span>
   <span class="font10">structure </span>
   <span class="font10">study. </span>
   <span class="font10">symptoms </span>
   <span class="font10">syndromeâ€�related </span>
   <span class="font10">therapy </span>
   <span class="font10">vaccine </span>
   <span class="font10">viruses, </span>
   <span class="font10">viruses. </span>
   <span class="font10">when </span>
   <span class="font10">will </span>
  </p>
 </body>
</html>
